Oncology Central

Melanomas’ fatal attraction to lysophosphatidic acid trails: a new prognostic and therapeutic approach?

0

Early-stage cutaneous melanoma is curable but advanced, metastatic melanoma is almost uniformly fatal [1]. Patients with such advanced disease have a short median survival of only 6–9 months [2]. Not only is cutaneous melanoma responsible for 75–80% of skin cancer deaths but there is an ongoing ‘melanoma epidemic’ [3].

Detecting and excising melanoma early is key to improving survival and melanoma is characterized by clinical and biological heterogeneity, which in part explains why melanoma is notoriously resistant to chemo- and immuno-therapeutic strategies [4,5].

To view restricted content, please:
Share:

Leave A Comment